# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Liver cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 731 results.
Primary Liver Cancer Cohort of South China
Status: Recruiting
Last Changed: Sep 29, 2017
First Received: Sep 29, 2017
Disease(s): Primary Liver Cancer
Locations: Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Liver Cancer Community Education
Status: Not yet recruiting
Last Changed: Feb 20, 2020
First Received: Feb 17, 2020
Disease(s): Liver Cancer
Intervention(s): LIVE-R Life Education
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
Status: Recruiting
Last Changed: Sep 12, 2019
First Received: Apr 02, 2018
Disease(s): Advanced Liver Cancer
Intervention(s): Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Liver Cancer, cryotherapy
Locations: Biological treatment center in Fuda cancer hospital, Guangzhou, Guangdong, China
Institutional Review Board of Guangzhou Fuda Cancer Hospital, Guangzhou, Guangdong, China
Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer
Status: Recruiting
Last Changed: Sep 03, 2019
First Received: May 10, 2017
Disease(s): Advanced Liver Cancer
Intervention(s): Activated CIK and bispecific antibody, Activated CIK
Locations: 302 Military Hospital of China, Beijing, Beijing, China
Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer
Status: Recruiting
Last Changed: Feb 18, 2019
First Received: Feb 18, 2019
Disease(s): Liver Cancer
Intervention(s): Cinobufacini injection, Transarterial Chemoembolization(TACE), cinobufacini tablet
Locations: The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients
Status: Recruiting
Last Changed: Feb 24, 2020
First Received: Mar 27, 2019
Disease(s): Liver Cancer
Intervention(s): Dynamic Contrast Enhanced Computed Tomography
Locations: University of Colorado Denver, Aurora, Colorado, United States
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Status: Recruiting
Last Changed: Sep 13, 2019
First Received: Dec 31, 2014
Disease(s): Liver Cancer
Intervention(s): Irreversible electroporation (IRE)
Locations: FUDA Cancer Hospital, Guangzhou, Guangdong, China
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
Status: Recruiting
Last Changed: Nov 14, 2019
First Received: Nov 14, 2019
Disease(s): Advanced Liver Cancer
Intervention(s): PD-1, Sorafenib
Locations: TaoBai, Nanning, Guangxi, China
Infusion of Toripalimab Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma
Status: Recruiting
Last Changed: May 14, 2019
First Received: May 14, 2019
Disease(s): Liver Cancer
Intervention(s): Toripalimab
Locations: The Second Affiliated Hospital of Guangzhou Medical University, Guanzhou, Guangdong, China
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Status: Recruiting
Last Changed: Jul 20, 2018
First Received: Jul 19, 2018
Disease(s): HepatoCellular Carcinoma, Liver Cancer
Intervention(s): IKC (Immune Killer Cells), TACE (Transcatheter Arterial Chemoembolization)
Locations: Tri Service General Hospital, Taipei, Taiwan